Sarah Goldberg, MD

Sarah Goldberg, MD, MPH, assistant professor of Medicine and Medical Oncology, Yale Cancer Center, discusses coming trials looking at immunotherapy beyond the second-line setting in non-small cell lung cancer (NSCLC). Goldberg says the most exciting part about these trial is finding out if combination immunotherapy treatment regimens could work better than single-agent regimens.

Videos

Sarah Goldberg, MD, MPH, assistant professor of Medicine and Medical Oncology, Yale Cancer Center, discusses coming trials looking at immunotherapy beyond the second-line setting in non-small cell lung cancer (NSCLC).

Sarah Goldberg, MD | Authors

Articles

Dr. Sarah Goldberg on Further Immunotherapy Trials in Non-Small Cell Lung Cancer